Eptifibatide
Eptifibatide is an active ingredient in 21 FDA-listed drug products sold under 1 name.
Drugs containing Eptifibatide
- Eptifibatide 21
Products and strengths
| NDC | Product | Strength | Labeler |
|---|---|---|---|
| 83634-301 | Eptifibatide Injection, Solution | .75 mg/mL | Avenacy, LLC |
| 83634-300 | Eptifibatide Injection, Solution | 2 mg/mL | Avenacy, LLC |
| 0338-9558 | Eptifibatide Injection | 75 mg/100mL | Baxter Healthcare Company |
| 55150-218 | Eptifibatide Injection | 75 mg/100mL | Eugia US LLC |
| 55150-220 | Eptifibatide Injection | 200 mg/100mL | Eugia US LLC |
| 55150-219 | Eptifibatide Injection | 20 mg/10mL | Eugia US LLC |
| 52958-402 | Eptifibatide Injection, Solution | 2 mg/mL | Hainan Shuangcheng Pharmaceuticals Co., Ltd. |
| 52958-040 | Eptifibatide Injection, Solution | .75 mg/mL | Hainan Shuangcheng Pharmaceuticals Co., Ltd. |
| 71288-413 | Eptifibatide Injection, Solution | .75 mg/mL | Meitheal Pharmaceuticals Inc. |
| 71288-412 | Eptifibatide Injection, Solution | 2 mg/mL | Meitheal Pharmaceuticals Inc. |
| 67457-629 | Eptifibatide Injection, Solution | 2 mg/mL | Mylan Institutional LLC |
| 72078-026 | Eptifibatide Injection, Solution | .75 mg/mL | Mylan Institutional LLC |
| 72078-027 | Eptifibatide Injection, Solution | 2 mg/mL | Mylan Institutional LLC |
| 72078-025 | Eptifibatide Injection, Solution | 2 mg/mL | Mylan Institutional LLC |
| 67457-631 | Eptifibatide Injection, Solution | .75 mg/mL | Mylan Institutional LLC |
| 67457-630 | Eptifibatide Injection, Solution | 2 mg/mL | Mylan Institutional LLC |
| 25021-408 | Eptifibatide Injection, Solution | .75 mg/mL | Sagent Pharmaceuticals |
| 70436-162 | Eptifibatide Injection | 2 mg/mL | Slate Run Pharmaceuticals, LLC |
| 70436-026 | Eptifibatide Injection | 2 mg/mL | Slate Run Pharmaceuticals, LLC |
| 70436-027 | Eptifibatide Injection | .75 mg/mL | Slate Run Pharmaceuticals, LLC |
| 70436-163 | Eptifibatide Injection | .75 mg/mL | Slate Run Pharmaceuticals, LLC |